Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CEO Calvin H. Knowlton sold 8,000 shares of the firm’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $32.75, for a total transaction of $262,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) traded down $0.12 during trading on Thursday, hitting $35.71. 191,796 shares of the stock traded hands, compared to its average volume of 211,036. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.66 and a current ratio of 0.73. Tabula Rasa HealthCare Inc has a 1-year low of $11.59 and a 1-year high of $38.23. The firm has a market cap of $687.29 and a price-to-earnings ratio of -210.06.
Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its earnings results on Monday, November 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.02. Tabula Rasa HealthCare had a negative net margin of 2.27% and a negative return on equity of 5.58%. The business had revenue of $33.27 million for the quarter, compared to analyst estimates of $31.76 million. During the same period in the previous year, the business earned $0.06 EPS. The firm’s revenue was up 37.6% on a year-over-year basis. sell-side analysts predict that Tabula Rasa HealthCare Inc will post 0.03 earnings per share for the current year.
Several research analysts recently commented on the stock. Zacks Investment Research upgraded shares of Tabula Rasa HealthCare from a “hold” rating to a “strong-buy” rating and set a $31.00 target price on the stock in a report on Wednesday, October 11th. Robert W. Baird reiterated an “outperform” rating and issued a $30.00 target price (up previously from $22.00) on shares of Tabula Rasa HealthCare in a report on Tuesday, October 17th. Wells Fargo & Co lifted their target price on shares of Tabula Rasa HealthCare from $21.00 to $27.00 and gave the stock a “market perform” rating in a report on Thursday, October 19th. Piper Jaffray Companies reiterated a “buy” rating and issued a $29.00 target price on shares of Tabula Rasa HealthCare in a report on Tuesday, October 24th. Finally, First Analysis initiated coverage on shares of Tabula Rasa HealthCare in a research report on Wednesday, November 1st. They issued an “overweight” rating and a $41.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $29.78.
Several institutional investors have recently modified their holdings of TRHC. Peregrine Capital Management LLC acquired a new stake in shares of Tabula Rasa HealthCare during the 4th quarter valued at about $9,122,000. Pier Capital LLC acquired a new stake in shares of Tabula Rasa HealthCare during the 3rd quarter valued at about $4,151,000. Wasatch Advisors Inc. acquired a new stake in shares of Tabula Rasa HealthCare during the 3rd quarter valued at about $4,047,000. EAM Investors LLC acquired a new stake in shares of Tabula Rasa HealthCare during the 3rd quarter valued at about $3,931,000. Finally, Allianz Asset Management GmbH acquired a new position in Tabula Rasa HealthCare in the third quarter valued at about $3,801,000. Institutional investors and hedge funds own 32.14% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Insider Selling: Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CEO Sells 8,000 Shares of Stock” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/01/tabula-rasa-healthcare-inc-trhc-ceo-calvin-h-knowlton-sells-8000-shares-of-stock.html.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.